Democratic governors and reproductive health groups are closely watching whether the Biden administration will soon require health plans to cover the first daily over-the-counter oral birth control pill hitting retail and pharmacy shelves later this month.
Pharmaceutical company
Opill, which the Food and Drug Administration in July approved to be available ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
